Administer twice weekly for up to 4 weeks maximum of 8 injections at approved dosage of 2 mg lb body weight 0 02 ml lb or 1 ml 50 lb by intramuscular im injection only.
Adequan dosage for canines.
The recommended adequan dose for dogs is 2 mg per lb of body weight given only by intramuscular im injection twice a week for up to 4 weeks a maximum of 8 injections.
The recommended dose of adequan canine is 2 mg lb body weight 02 ml lb or 1 ml per 50 lb by intramuscular injection only twice weekly for up to 4 weeks maximum of 8 injections.
Adequan helps relieve the pain of arthritis by soothing and lubricating the inflamed joint in addition to stimulating joint cartilage repair.
It has to be administered in a series of 8 injections.
Your veterinarian will determine the appropriate dose for your pet.
Important safety information adequan canine should not be used in dogs who are hypersensitive to psgag or who have a known or suspected bleeding disorder.
Do not mix adequan canine with other drugs or solvents.
The drug works by inhibiting one of the enzymes responsible for breaking down.
Adequan canine is a medication for the treatment of arthritis in dogs.
The recommended dose of adequan canine is 2 mg lb body weight 02 ml lb or 1 ml per 50 lb by intramuscular injection only twice weekly for up to 4 weeks maximum of 8 injections.
Currently adequan is only fda approved for dogs and horses though some vets do prescribe it for cats as well.
This dose of adequan canine should be injected intramuscularly twice a week for 4 weeks.
Dosage of adequan canine.
Although improvement is generally observed after the second injection cartilage erosion ceases after the.
Do not exceed the recommended dose or therapeutic regimen.
It should be used with caution in dogs with renal or hepatic impairment.
The recommended dosage is 2mg per pound of the dog s weight.
Read on to learn about adequan for dogs the correct dosage safety precautions side effects and uses of the medicine.
Adequan canine is the only fda approved injectable disease modifying osteoarthritis drug dmoad for dogs.
Use adequan canine early at the first clinical signs of oa before it progresses and cartilage is irreversibly damaged.
Veterinarians may repeat the 1 4 7 series as needed upon recurrence of the clinical signs of djd.
At the approved dose 500 mg to achieve improvement shown in studies.
2 do not exceed the recommended dose or therapeutic regimen.
Do not exceed the recommended dose or therapeutic regimen.
It is recommended for the control of signs associated with non infectious degenerative and or traumatic arthritis of canine synovial joints.
At early signs of degenerative joint disease veterinarians can administer adequan i m.
